These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36652844)

  • 1. Generation of an induced pluripotent stem cell (iPSC) line from a patient with GEFS+ carrying a STX1B (p.Lys45delinsArgMetCysIleGlu and p.Leu46Met) mutation.
    Haag C; Uysal B; Marquetand J; Löffler H; Mau-Holzmann UA; Lerche H; Schwarz N
    Stem Cell Res; 2023 Mar; 67():103028. PubMed ID: 36652844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy-causing STX1B mutations translate altered protein functions into distinct phenotypes in mouse neurons.
    Vardar G; Gerth F; Schmitt XJ; Rautenstrauch P; Trimbuch T; Schubert J; Lerche H; Rosenmund C; Freund C
    Brain; 2020 Jul; 143(7):2119-2138. PubMed ID: 32572454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A novel inherited STX1B mutation associated with generalized epilepsy with febrile seizures plus: a family analysis and literature review].
    Tian Y; Hou C; Wang XY; Yang ZX; Ma YL; Cao BB; Li XJ
    Zhonghua Er Ke Za Zhi; 2019 Mar; 57(3):206-210. PubMed ID: 30818898
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes.
    Schubert J; Siekierska A; Langlois M; May P; Huneau C; Becker F; Muhle H; Suls A; Lemke JR; de Kovel CG; Thiele H; Konrad K; Kawalia A; Toliat MR; Sander T; Rüschendorf F; Caliebe A; Nagel I; Kohl B; Kecskés A; Jacmin M; Hardies K; Weckhuysen S; Riesch E; Dorn T; Brilstra EH; Baulac S; Møller RS; Hjalgrim H; Koeleman BP; ; Jurkat-Rott K; Lehman-Horn F; Roach JC; Glusman G; Hood L; Galas DJ; Martin B; de Witte PA; Biskup S; De Jonghe P; Helbig I; Balling R; Nürnberg P; Crawford AD; Esguerra CV; Weber YG; Lerche H
    Nat Genet; 2014 Dec; 46(12):1327-32. PubMed ID: 25362483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor cortex excitability in seizure-free STX1B mutation carriers with a history of epilepsy and febrile seizures.
    Stefanou MI; Desideri D; Marquetand J; Belardinelli P; Zrenner C; Lerche H; Ziemann U
    Clin Neurophysiol; 2017 Dec; 128(12):2503-2509. PubMed ID: 29101845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation.
    Schwarz N; Uysal B; Rosa F; Löffler H; Mau-Holzmann UA; Liebau S; Lerche H
    Stem Cell Res; 2019 May; 37():101445. PubMed ID: 31075689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntaxin 1B regulates synaptic GABA release and extracellular GABA concentration, and is associated with temperature-dependent seizures.
    Mishima T; Fujiwara T; Kofuji T; Saito A; Terao Y; Akagawa K
    J Neurochem; 2021 Mar; 156(5):604-613. PubMed ID: 32858780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell (iPSC) line (HIHDNEi003-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Thr374Ala) mutation.
    Uysal B; Löffler H; Rosa F; Lerche H; Schwarz N
    Stem Cell Res; 2019 Oct; 40():101543. PubMed ID: 31465893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell line from an epilepsy patient carrying mutations in the PIK3R2 gene.
    Zhang B; Wang Y; Peng J; Hao Y; Guan Y
    Stem Cell Res; 2020 Apr; 44():101711. PubMed ID: 32155459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of
    Wolking S; May P; Mei D; Møller RS; Balestrini S; Helbig KL; Altuzarra CD; Chatron N; Kaiwar C; Stöhr K; Widdess-Walsh P; Mendelsohn BA; Numis A; Cilio MR; Van Paesschen W; Svendsen LL; Oates S; Hughes E; Goyal S; Brown K; Sifuentes Saenz M; Dorn T; Muhle H; Pagnamenta AT; Vavoulis DV; Knight SJL; Taylor JC; Canevini MP; Darra F; Gavrilova RH; Powis Z; Tang S; Marquetand J; Armstrong M; McHale D; Klee EW; Kluger GJ; Lowenstein DH; Weckhuysen S; Pal DK; Helbig I; Guerrini R; Thomas RH; Rees MI; Lesca G; Sisodiya SM; Weber YG; Lal D; Marini C; Lerche H; Schubert J
    Neurology; 2019 Mar; 92(11):e1238-e1249. PubMed ID: 30737342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an induced pluripotent stem cell line (EURACi014-A) from a Parkinson's disease patient with an A53T mutation in the SNCA gene by an integration-free reprogramming method.
    Gilmozzi V; Gentile G; Riekschnitz DA; Volpato CB; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
    Stem Cell Res; 2022 Apr; 60():102713. PubMed ID: 35189566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line SYSUi-003-A from a child with epilepsy carrying GRIN2A mutation.
    Sun C; Yang M; Qin F; Guo R; Liang S; Hu H
    Stem Cell Res; 2020 Mar; 43():101706. PubMed ID: 32036246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell (iPSC) line from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Leu328Val) mutation.
    Schwarz N; Uysal B; Rosa F; Löffler H; Mau-Holzmann UA; Liebau S; Lerche H
    Stem Cell Res; 2018 Dec; 33():6-9. PubMed ID: 30292882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
    Shan W; Yang X; Ren Q; Wang Q
    Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an induced pluripotent stem cell (iPSC) line (BBANTWi009-A) from a Meester-Loeys syndrome patient carrying a BGN mutation.
    De Kinderen P; Rabaut L; Hebert A; Ponsaerts P; Perik M; Meester JAN
    Stem Cell Res; 2023 Feb; 66():103009. PubMed ID: 36599284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy.
    Zhao H; Li S; He L; Han X; Huang H; Tang F; Lin Z; Deng S; Tian C; Huang R; Li Z
    Stem Cell Res; 2020 May; 45():101785. PubMed ID: 32335389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.